This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Snap rebuts 'false and reprehensible' claim it enabled US drug crisis

By Maria Dinzeo ( May 12, 2025, 22:08 GMT | Insight) -- Snap Inc. is rebutting claims in a wrongful death suit brought by parents of children who died from fentanyl poisoning, calling accusations that it ignored or enabled drug sales on its platform “false and reprehensible.”Snap Inc. is pushing back on a wrongful death lawsuit by parents who lost children due to fentanyl poisoning, calling allegations that it was indifferent to drugs being sold on its platform — or even purposefully facilitated the teen drug overdose epidemic — “false and reprehensible.”...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login